Additive interaction between tamoxifen and rifampicin in human biliary tract carcinoma cells.
AffiliationDepartment of Radiobiology, Paterson Institute for Cancer Research, Manchester, U.K.
MetadataShow full item record
AbstractA novel two-drug combination of tamoxifen and rifampicin has been investigated for the treatment of biliary tract-associated malignancies. Their effects, alone and in combination, on human tumour cells were studied using two pancreatic carcinoma cell lines. MIA PaCa-2 and AsPC-1, and a gall bladder carcinoma cell line, G-415. Inhibition of growth was used as an endpoint. The cells differed in sensitivity to equimolar doses of the two drugs given as single agents. Combined doses of rifampicin and tamoxifen resulted in growth inhibition to an extent that was suggestive of additive or synergistic drug effects. More detailed analysis was carried out, involving the production of an 'envelope of additivity' for each cell line. An additive effect of drug combination was shown to occur in all three cell lines, thus providing a basis for use of this novel two-drug combination in the treatment of biliary tract-associated malignancies.
CitationAdditive interaction between tamoxifen and rifampicin in human biliary tract carcinoma cells. 1990, 55 (2):159-63 Cancer Lett.
- Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro.
- Authors: Tanos V, Brzezinski A, Drize O, Strauss N, Peretz T
- Issue date: 2002 May 10
- Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
- Authors: Pu YS, Hsieh TS, Cheng AL, Tseng NF, Su IJ, Hsieh CY, Lai MK, Tsai TC
- Issue date: 1996 Jan
- Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.
- Authors: Yip-Schneider MT, Nakshatri H, Sweeney CJ, Marshall MS, Wiebke EA, Schmidt CM
- Issue date: 2005 Apr
- Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth.
- Authors: Heisler T, Towfigh S, Simon N, Liu C, McFadden DW
- Issue date: 2000 Jan
- Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
- Authors: Zhu ZW, Friess H, Wang L, Bogardus T, Korc M, Kleeff J, Büchler MW
- Issue date: 2001 Jan